Who is sponsoring NCT02736773?

NCT02736773 is sponsored by University Hospital, Montpellier.

What drugs are being tested in NCT02736773?

Interventions in NCT02736773: xenograft material to slow resorption.

What condition does NCT02736773 study?

NCT02736773 studies Xenograft Model.

Is NCT02736773 still recruiting?

NCT02736773 is currently completed. Last updated 5 August 2019.

Last reviewed 2019-08-05 · How we verify

NCT02736773: Flapless

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Xenograft and Posterior Mandibular Socket Filling

Completed NA Last updated 5 August 2019

What this trial tests

NA trial testing xenograft material to slow resorption in Xenograft Model in 35 participants. Completed in 1 September 2018.

Timeline

1 December 2015

Primary endpoint
1 June 2018

1 September 2018

Quick facts

Lead sponsor	University Hospital, Montpellier
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	35
Start date	1 December 2015
Primary completion	1 June 2018
Estimated completion	1 September 2018
Sites	1 location across France

Drugs / interventions tested

xenograft material to slow resorption

Conditions studied

Xenograft Model — all drugs for Xenograft Model →

Sponsor

University Hospital, Montpellier

Who can join

Adults 18 to 75, any sex, with Xenograft Model. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the volume of madibular bone after placement of a xenograft in a fresh extraction socket in human. The surgery protocol is flapless, and the teeth are mandibular premolars or molars leaving sockets with 4 walls intact or at least 3 walls intact and the buccal wall at 80% . This study will include 35 patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02736773 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 5 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02736773.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing